Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban

In Newsletter 14 of February 2019 P. Meijer has reviewed the publication influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban

Related items

Analytical Information : 1

Cases : 1

Guidelines : 2

Quality Issues : 1

Clotpedia

ECAT Foundation
P.O. Box 107
2250 AC Voorschoten | The Netherlands
Email: info@ecat.nl
T: +31 (0) 71 3030 910 | F: +31 (0) 71 3030 919

Disclaimer
ECAT collaborates with the website Practical-Hemostasis.com. Ecat is not responsible for the content of this website.
Clotpedia includes content of the former website Clot-ed.com (owned by Marlies Ledford-Kramer)

Analytical Information

Assays

Cases

ECAT Documentation

Guidelines

Haemostatic Cascade

Parameter

Quality Issues

Surveys and Studies

Terminology

Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban

Related items

Interference of rivaroxaban in one-stage and chromogenic factor VIII:C assays

Acquired Hemophilia A, case study

ICSH Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Update Recommendations for Laboratory Measurement of Direct Oral Anticoagulants, ICSH recommendations

External quality assessment for Rivaroxaban and Dabigatran

Clotpedia

© 2022 ECAT Clotpedia All Rights Reserved

ECAT Foundation
P.O. Box 107
2250 AC Voorschoten | The Netherlands
Email: info@ecat.nl
T: +31 (0) 71 3030 910 | F: +31 (0) 71 3030 919

Disclaimer
ECAT collaborates with the website Practical-Hemostasis.com. Ecat is not responsible for the content of this website.
Clotpedia includes content of the former website Clot-ed.com (owned by Marlies Ledford-Kramer)

Clotpedia Support Form

Success

Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban

Related items

Interference of rivaroxaban in one-stage and chromogenic factor VIII:C assays

Acquired Hemophilia A, case study

ICSH Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Update Recommendations for Laboratory Measurement of Direct Oral Anticoagulants, ICSH recommendations

External quality assessment for Rivaroxaban and Dabigatran

Clotpedia

© 2022 ECAT Clotpedia All Rights Reserved

ECAT Foundation P.O. Box 107 2250 AC Voorschoten | The Netherlands Email: info@ecat.nl T: +31 (0) 71 3030 910 | F: +31 (0) 71 3030 919

Disclaimer ECAT collaborates with the website Practical-Hemostasis.com. Ecat is not responsible for the content of this website. Clotpedia includes content of the former website Clot-ed.com (owned by Marlies Ledford-Kramer)

ECAT Foundation
P.O. Box 107
2250 AC Voorschoten | The Netherlands
Email: info@ecat.nl
T: +31 (0) 71 3030 910 | F: +31 (0) 71 3030 919

Disclaimer
ECAT collaborates with the website Practical-Hemostasis.com. Ecat is not responsible for the content of this website.
Clotpedia includes content of the former website Clot-ed.com (owned by Marlies Ledford-Kramer)